May 2012 FDA Recall Drug by Bayer Healthcare Pharmaceuticals Inc.
D-1433-2012 - Cross Contamination w/Other Products
This Class II drug recall was voluntarily initiated by Bayer Healthcare Pharmaceuticals Inc. on May 8, 2012 for the product Drug. The FDA reported the reason for recall as cross contamination w/other products. The product was distributed in Kansas and California. and the recall is currently terminated.
Recall Number: D-1433-2012
Cross Contamination w/Other Products: This active pharmaceutical ingredient is being recalled due to cross contamination with another product.
05-08-2012
08-08-2012
112.295 kg
Recall Profile & Regulatory Data
Class II - is a situation in which use of, or exposure to, a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote
Enforcement Status About Enforcement Status
Current regulatory stage of the recall event.
Current regulatory stage of the recall event.
Terminated
Recalling Firm About Recalling Firm
The firm responsible for the recall.
The firm responsible for the recall.
Bayer HealthCare Pharmaceuticals Inc.
Voluntary / Mandated About Voluntary / Mandated
Indicates if the firm acted on its own or under FDA order.
Indicates if the firm acted on its own or under FDA order.
Voluntary: Firm initiated
Drugs
Initial Notification About Initial Notification
Method by which the firm first notified the public.
Method by which the firm first notified the public.
Letter
Distribution Pattern About Distribution Pattern
General area of initial distribution.
General area of initial distribution.
Kansas and California.
12-18-2012
Product Description About Product Description
Full technical description of the product.
Full technical description of the product.
Estradiol Hemihydrate M20 EP/USP Powder, packaged in a) 1.5 kg and b) 2.5 kg fiber drums, Rx only, Art. No. 165811, Bayer Pharma AG, D-13342 Berlin.
Batch or Lot Expiration Information
Lot# Lot Number: 81202450, Exp 06/15/16